Email Updates

You are here

Home

20 SEPTEMBER 2019 VOLUME 20 ISSUE 36

Media Coverage

  • Program in Kenyan Family Planning Clinics Connects At-Risk Women to PrEP

    Almost a quarter of at-risk women screened at family planning clinics in Kenya initiated pre-exposure prophylaxis, or PrEP, for HIV prevention, and more than 40 percent of them returned for at least one refill, suggesting that integrating universal screening and counseling for PrEP in family planning clinics is feasible, researchers said.

    September 20, 2019
    PrEP
    Healio

  • In 1995, There Was No AIDS Conference -- Here's What Happened in 1994

    Twenty-five years ago, there appeared to be little hope for effective treatment in what had become a losing battle against the AIDS epidemic, and news out of the 10th International AIDS Conference (IAC) in Yokohama, Japan, in 1994 was equally bleak. So much so that the normally annual meeting was cancelled the following year.

    September 19, 2019
    Treatment
    MedPage Today

  • Opinion: How to Achieve the ‘Fourth 90’ for HIV

    Since 2014, the world has been working towards the 90-90-90 targets established by UNAIDS. These targets envision 90 percent of people living with HIV will know their HIV status by 2020, 90 percent of people who know their HIV-positive status will be on treatment, and 90 percent of people on treatment will have a suppressed viral load. However, there is a growing belief that 90-90-90 stops short of optimizing care for people living with HIV.

    September 19, 2019
    General
    Devex

  • Botswana: STIs, HIV Remain Twin Challenge in Botswana

    Sexually Transmitted Infections (STIs) remain a public health problem in Botswana given its role in the transmission of HIV. This was said by the National AIDS and Health Promotion Agency (NAHPA) coordinator Mr Richard Matlhare who added that the challenge needed to be addressed with vigor.

    September 19, 2019
    General
    All Africa

  • Advocates Say Gilead Broke Antitrust Laws

    A group of advocates has filed a federal class action lawsuit against Gilead Sciences Inc. and its partner companies, alleging that they violated antitrust laws and established an HIV treatment monopoly by agreeing to combine their medications in exclusive coformulations.

    September 18, 2019
    PrEP, Treatment
    Bay Area Reporter

  • Only HIV Vax to Show Any Efficacy Prompted Strong Immune Response in New Study

    The only HIV vaccine regimen ever to demonstrate any efficacy has prompted strong antibody and cellular immune responses in a new trial that enrolled South African participants. This finding has led researchers to believe that it may not be necessary to tailor HIV vaccines to different regions of the world based on the different predominant circulating strains of the virus.

    September 18, 2019
    HIV Vaccine
    POZ

  • Lesotho Achieves Second 90 After Rapid Treatment Expansion

    Lesotho has reached the second 90 of the UNAIDS targets, with 91.8 percent of people living with HIV who are aware of their status on treatment. It is also close to reaching the third 90, with 87.7 percent of people who are diagnosed and on treatment virally suppressed.

    September 17, 2019
    Treatment
    Avert

  • There’s a Way for Modern Medicine to Cure Diseases Even When the Treatments Aren’t Profitable

    Strides in medicine have contributed to a dramatic increase in life expectancy over the last century. Diseases like HIV and cervical cancer that were essentially death sentences as recently as 30 years ago can now be managed with access to prescription drugs and surgical procedures.

    September 16, 2019
    General
    The Conversation

  • Sex Workers in Malawi Deal With HIV, Contraception and Violence

    Malawi has one of the world's highest rates of HIV, with sex workers considerably more likely to contract the infection. Rates of unwanted pregnancy and STI infections are also high.

    September 16, 2019
    General
    BBC

  • New HIV Infections Hit Record Low in SF, but People of Color, Homeless Cases Spike

    The number of new HIV diagnoses in San Francisco has dropped to a record low, but the news was more sober for four groups with a rising number of new cases: black and Latino residents, as well as homeless people and intravenous drug users, the city reported Tuesday.

    September 10, 2019
    General
    San Francisco Chronicle

Published Research

Announcements